16 Sep 2016 A slew of major Wall Street analysts downgraded the stock to neutral Friday including Citi Research, Piper Jaffray, JPMorgan and Wedbush.

NVAX | Novavax Inc. Analyst Estimates | MarketWatch Nov 08, 2019 · Novavax Inc. analyst estimates by MarketWatch. View NVAX revenue estimates and earnings estimates, as well as analyst recommendations. NVAX Price Target and Analyst Ratings (Novavax) | MarketBeat Nov 10, 2019 · Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.

NVAX Stock | NOVAVAX Stock Price Today | Markets Insider

View Novavax, Inc. NVAX investment & stock information. Get the latest Novavax, Inc. NVAX detailed stock quotes, stock data, All Zacks' Analyst Reports  View today's stock price, news and analysis for Novavax Inc. (NVAX). Barron's also provides information on historical stock ratings, target prices, company  FIRM, ANALYST. B. Riley FBR, George Zavoico, PhD. Cantor Fitzgerald, Charles Duncan, PhD. Chardan, Keay Nakae. H.C. Wainwright & Co. Vernon  26 Mar 2020 Analyst recommendations provided by FactSet shows that the consensus forecast for Novavax Inc. (NVAX) is a “Buy”. 5 analysts offering their 

NVAX - Novavax Stock Analyst Ratings - Barchart.com

Find the latest analyst research for Novavax, Inc. Common Stock (NVAX) at Nasdaq.com. Stock Price Forecast. The 5 analysts offering 12-month price forecasts for Novavax Inc have a median target of 23.00, with a high estimate of 24.00 and a low  Novavax Inc. analyst estimates by MarketWatch. View NVAX revenue estimates and earnings estimates, as well as analyst recommendations. Novavax Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NVAX updated stock price target summary. See Novavax, Inc. (NVAX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Analyst Ratings for Novavax Inc (NVAX) provide recommendations made by outside industry experts.

Novavax Stock Forecast: down to 9.515 USD? - NVAX Stock ...

See Novavax price target based on 5 analysts offering 12 month price targets for Novavax in the last 3 months. The average price target is $22.00 with a high forecast of $24.00 and a low forecast of $19.00. The average price target represents a 58.73% increase from the last price of $13.86.

Mar 25, 2020 · NVAX has either issued a significant amount of new shares over the past year or has been issuing more and more shares over the past five years. NVAX currently has 270.0 million shares outstanding. Neither of these are a good sign. Generally when a small-cap company issues more stock, the existing stock becomes devalued by the market, and hence

NVAX | Novavax Inc. Stock Price & News - WSJ

AbbVie Gains Pre-Earnings on Analyst Nod, Coronavirus Drug Demand Novavax Falls Again After New Data on RSV Vaccine Fails to Excite Pacific Biosciences Shares Lower After Pricing Stock